On December 19, 2020, Dr. H.Fai Poon, CEO of QuaCell Biotechnology, Co., Ltd. (hereinafter referred to as "QuaCell"), was invited to participate in the Guangzhou Biomedical Innovation and R&D Forum of the 2020 International Trade Fair.

The forum was held at the Baiyun International Conference Center. More than 200 people, including pharmaceutical entrepreneurs, innovative scientists, and investors, participated in the forum. They discussed the research and development of innovative biomedical drugs, clinical research, and biological treatment, and exchanged cutting-edge technologies and practical experience, showing the frontier development trends in this field, promoting the development and industrialization of biopharmaceuticals, and discussing cooperation in production, education and research projects in the biomedical industry.

Dr. Poon, CEO of QuaCell Biotechnology, and colleagues discussed the development strategies and strategic layout of innovative biological drugs such as antibodies, polysaccharides, microbes, and combination drugs, better promoting in-depth view sharing in the biomedical industry. Under their active interaction, the mind map of the development of the biomedical industry has become clearer with the exchange of talents as the engine, agglomeration to form a new driving force for the development of the biomedical industry and accelerate the construction of a new development pattern with domestic and international cycles as the main body and mutual promotion of domestic and international cycles.

Relying on the high-quality human resources of famous universities, famous companies, and through keynote speeches, round-table discussions, and other methods, this forum has once again deepened the exchanges and cooperation of the pharmaceutical industry in technical seminars, talent introduction, project cooperation, etc., and helped promote the optimization of the biomedical industry in Eastern Province. This platform also promotes the gathering of overseas talents and is an important hub for the two-way integrated development of enterprises and talents, technology and transformation, technological innovation chain, and industrial chain.